Biomaterials Liability Bill Cleared For President's Signature
This article was originally published in The Gray Sheet
Executive Summary
The "Biomaterials Access Assurance Act" (HR 872), passed by the House July 29 and the Senate July 30, is expected to be signed by President Clinton.
You may also be interested in...
Bringing Back Innovation: FDA Science Board Discusses Biomaterials Access
Further research into biomaterials, including the development of testing methodologies, would aid device development, participants suggested at an April 9 FDA Science Board meeting held in Rockville, Maryland
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.